Replies to post #424 on Fate Therapeutics Inc (FATE)

[jondoeuk]

Notch will present at ASH

A Regulated Cytokine Engineering Strategy to Augment in Vitro and In Vivo persistence of Allogeneic iPSC Derived CD8 T-Cells https://ash.confex.com/ash/2024/webprogram/Paper211835.html

A Layered Cloaking Strategy to Generate Allogeneic iPSC-Derived CD8 T-Cells That Evade NK Clearance https://ash.confex.com/ash/2024/webprogram/Paper210003.html